Table 2.
Strain | MIC (µg/ml)b |
FICIc | MIC (µg/ml)b |
FICIc | |||
---|---|---|---|---|---|---|---|
BEA[a] | KTC[a] | KTC[c] | ICZ[a] | ICZ[c] | |||
Candida albicans SC5314 | 8 | 0.008 | 0.002 | 0.5 | 0.032 | 0.004 | 0.375 |
Candida tropicalisa | 16 | 1.6–3.2 | <0.064 | <0.145 | 0.032 | 0.008 | 0.5 |
Candida kruseia | >32 | 0.8–1.6 | 0.025 | <0.28 | 0.5 | 0.064 | 0.378 |
Candida parapsilosis ATCC14054 | 16 | 0.025 | <0.0064 | <0.5 | 0.25 | 0.004 | 0.266 |
Clinical isolates;
[a], alone, [c], combination with 1/4MIC of BEA;
FICI = (MICdrug A in combination/MICdrug A alone) + (MICdrug B in combination/MICdrug B alone), (FICI > 4: Antagonism; FICI < 0.5: Synergy; 0.5 < FICI < 4: Additive).